Is Elegant Floricul overvalued or undervalued?
As of September 19, 2025, Elegant Floricul is considered undervalued with a PE ratio of 6.21, significantly lower than peers like Trescon and Indrayani Biotec, and while it has outperformed the Sensex year-to-date, recent negative performance indicates potential volatility.
As of 19 September 2025, the valuation grade for Elegant Floricul has moved from very attractive to attractive, indicating a shift in perceived value. The company is currently assessed as undervalued. Key ratios include a PE ratio of 6.21, an EV to EBITDA of 8.07, and a Price to Book Value of 0.79, which suggest that the stock is trading at a significant discount compared to its earnings and asset value.In comparison to peers, Elegant Floricul's PE ratio of 6.21 stands in stark contrast to Trescon, which is considered very expensive with a PE of 1856.27, and Indrayani Biotec, which is classified as risky with a PE of 21.79. This further reinforces the undervaluation narrative. Additionally, while Elegant Floricul has outperformed the Sensex on a year-to-date basis with a return of 10.53% compared to the Sensex's 5.74%, its recent performance over the last week and month has been negative, suggesting potential volatility ahead.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
